ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Coagulation VIIa Market Insights, Forecast to 2030
Published Date: August 2024
|
Report Code: QYRE-Auto-1C11632
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Coagulation VIIa Market Research Report 2022
BUY CHAPTERS

Global Recombinant Human Coagulation VIIa Market Insights, Forecast to 2030

Code: QYRE-Auto-1C11632
Report
August 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
Generium

Recombinant Human Coagulation VIIa Market Size

The global Recombinant Human Coagulation VIIa market is projected to grow from US$ 1179.9 million in 2024 to US$ 1467.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period.

Recombinant Human Coagulation VIIa Market

Recombinant Human Coagulation VIIa Market

Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade.
The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%. The largest manufacturer is Novo Nordisk, with a market share of more than 95%. North America is the global most important consumer market for recombinant human coagulation VIIa, with a market share of about 45%. In terms of type, the market share of prefilled syringe is over 78%. In the field of application, the market share of congenital hemophilia is about 65%.
Report Covers:
This report presents an overview of global market for Recombinant Human Coagulation VIIa, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Human Coagulation VIIa, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Coagulation VIIa, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Human Coagulation VIIa sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Human Coagulation VIIa market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Human Coagulation VIIa sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Recombinant Human Coagulation VIIa Market Report

Report Metric Details
Report Name Recombinant Human Coagulation VIIa Market
Accounted market size in 2024 US$ 1179.9 million
Forecasted market size in 2030 US$ 1467.3 million
CAGR 3.7
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Prefilled Syringe
  • Vial
Segment by Application
  • Congenital Hemophilia
  • Acquired Hemophilia
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AryoGen Pharmed, GENERIUM
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Recombinant Human Coagulation VIIa in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Recombinant Human Coagulation VIIa manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Coagulation VIIa sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Human Coagulation VIIa Market growing?

Ans: The Recombinant Human Coagulation VIIa Market witnessing a CAGR of 3.7 during the forecast period 2024-2030.

What is the Recombinant Human Coagulation VIIa Market size in 2030?

Ans: The Recombinant Human Coagulation VIIa Market size in 2030 will be US$ 1467.3 million.

What is the market share of major companies in Recombinant Human Coagulation VIIa Market?

Ans: The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%.

What is the Recombinant Human Coagulation VIIa Market share by type?

Ans: In terms of type, the market share of prefilled syringe is over 78%.

What is the Recombinant Human Coagulation VIIa Market share by application?

Ans: In the field of application, the market share of congenital hemophilia is about 65%.

Who are the main players in the Recombinant Human Coagulation VIIa Market report?

Ans: The main players in the Recombinant Human Coagulation VIIa Market are AryoGen Pharmed, GENERIUM

What are the Application segmentation covered in the Recombinant Human Coagulation VIIa Market report?

Ans: The Applications covered in the Recombinant Human Coagulation VIIa Market report are Congenital Hemophilia, Acquired Hemophilia, Others

What are the Type segmentation covered in the Recombinant Human Coagulation VIIa Market report?

Ans: The Types covered in the Recombinant Human Coagulation VIIa Market report are Prefilled Syringe, Vial

1 Study Coverage
1.1 Recombinant Human Coagulation VIIa Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Coagulation VIIa Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Prefilled Syringe
1.2.3 Vial
1.3 Market by Application
1.3.1 Global Recombinant Human Coagulation VIIa Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Congenital Hemophilia
1.3.3 Acquired Hemophilia
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Coagulation VIIa Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant Human Coagulation VIIa Revenue by Region
2.2.1 Global Recombinant Human Coagulation VIIa Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant Human Coagulation VIIa Revenue by Region (2019-2024)
2.2.3 Global Recombinant Human Coagulation VIIa Revenue by Region (2025-2030)
2.2.4 Global Recombinant Human Coagulation VIIa Revenue Market Share by Region (2019-2030)
2.3 Global Recombinant Human Coagulation VIIa Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant Human Coagulation VIIa Sales by Region
2.4.1 Global Recombinant Human Coagulation VIIa Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant Human Coagulation VIIa Sales by Region (2019-2024)
2.4.3 Global Recombinant Human Coagulation VIIa Sales by Region (2025-2030)
2.4.4 Global Recombinant Human Coagulation VIIa Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Coagulation VIIa Sales by Manufacturers
3.1.1 Global Recombinant Human Coagulation VIIa Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant Human Coagulation VIIa Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Coagulation VIIa in 2023
3.2 Global Recombinant Human Coagulation VIIa Revenue by Manufacturers
3.2.1 Global Recombinant Human Coagulation VIIa Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant Human Coagulation VIIa Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Coagulation VIIa Revenue in 2023
3.3 Global Key Players of Recombinant Human Coagulation VIIa, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant Human Coagulation VIIa Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Coagulation VIIa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Coagulation VIIa, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Coagulation VIIa, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Coagulation VIIa, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Coagulation VIIa Sales by Type
4.1.1 Global Recombinant Human Coagulation VIIa Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Coagulation VIIa Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Coagulation VIIa Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Coagulation VIIa Revenue by Type
4.2.1 Global Recombinant Human Coagulation VIIa Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Coagulation VIIa Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Coagulation VIIa Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Coagulation VIIa Price by Type
4.3.1 Global Recombinant Human Coagulation VIIa Price by Type (2019-2024)
4.3.2 Global Recombinant Human Coagulation VIIa Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Recombinant Human Coagulation VIIa Sales by Application
5.1.1 Global Recombinant Human Coagulation VIIa Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Coagulation VIIa Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Coagulation VIIa Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Coagulation VIIa Revenue by Application
5.2.1 Global Recombinant Human Coagulation VIIa Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Coagulation VIIa Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Coagulation VIIa Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Coagulation VIIa Price by Application
5.3.1 Global Recombinant Human Coagulation VIIa Price by Application (2019-2024)
5.3.2 Global Recombinant Human Coagulation VIIa Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant Human Coagulation VIIa Market Size by Type
6.1.1 US & Canada Recombinant Human Coagulation VIIa Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)
6.2 US & Canada Recombinant Human Coagulation VIIa Market Size by Application
6.2.1 US & Canada Recombinant Human Coagulation VIIa Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)
6.3 US & Canada Recombinant Human Coagulation VIIa Market Size by Country
6.3.1 US & Canada Recombinant Human Coagulation VIIa Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant Human Coagulation VIIa Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant Human Coagulation VIIa Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Coagulation VIIa Market Size by Type
7.1.1 Europe Recombinant Human Coagulation VIIa Sales by Type (2019-2030)
7.1.2 Europe Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)
7.2 Europe Recombinant Human Coagulation VIIa Market Size by Application
7.2.1 Europe Recombinant Human Coagulation VIIa Sales by Application (2019-2030)
7.2.2 Europe Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)
7.3 Europe Recombinant Human Coagulation VIIa Market Size by Country
7.3.1 Europe Recombinant Human Coagulation VIIa Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant Human Coagulation VIIa Sales by Country (2019-2030)
7.3.3 Europe Recombinant Human Coagulation VIIa Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Coagulation VIIa Market Size
8.1.1 China Recombinant Human Coagulation VIIa Sales (2019-2030)
8.1.2 China Recombinant Human Coagulation VIIa Revenue (2019-2030)
8.2 China Recombinant Human Coagulation VIIa Market Size by Application
8.2.1 China Recombinant Human Coagulation VIIa Sales by Application (2019-2030)
8.2.2 China Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Human Coagulation VIIa Market Size by Type
9.1.1 Asia Recombinant Human Coagulation VIIa Sales by Type (2019-2030)
9.1.2 Asia Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)
9.2 Asia Recombinant Human Coagulation VIIa Market Size by Application
9.2.1 Asia Recombinant Human Coagulation VIIa Sales by Application (2019-2030)
9.2.2 Asia Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)
9.3 Asia Recombinant Human Coagulation VIIa Sales by Region
9.3.1 Asia Recombinant Human Coagulation VIIa Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant Human Coagulation VIIa Revenue by Region (2019-2030)
9.3.3 Asia Recombinant Human Coagulation VIIa Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Recombinant Human Coagulation VIIa Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novo Nordisk Recombinant Human Coagulation VIIa Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 LFB SA HEMA Biologics
11.2.1 LFB SA HEMA Biologics Company Information
11.2.2 LFB SA HEMA Biologics Overview
11.2.3 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 LFB SA HEMA Biologics Recent Developments
11.3 AryoGen Pharmed
11.3.1 AryoGen Pharmed Company Information
11.3.2 AryoGen Pharmed Overview
11.3.3 AryoGen Pharmed Recombinant Human Coagulation VIIa Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 AryoGen Pharmed Recombinant Human Coagulation VIIa Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AryoGen Pharmed Recent Developments
11.4 GENERIUM
11.4.1 GENERIUM Company Information
11.4.2 GENERIUM Overview
11.4.3 GENERIUM Recombinant Human Coagulation VIIa Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 GENERIUM Recombinant Human Coagulation VIIa Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GENERIUM Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Coagulation VIIa Industry Chain Analysis
12.2 Recombinant Human Coagulation VIIa Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Coagulation VIIa Production Mode & Process
12.4 Recombinant Human Coagulation VIIa Sales and Marketing
12.4.1 Recombinant Human Coagulation VIIa Sales Channels
12.4.2 Recombinant Human Coagulation VIIa Distributors
12.5 Recombinant Human Coagulation VIIa Customers
13 Market Dynamics
13.1 Recombinant Human Coagulation VIIa Industry Trends
13.2 Recombinant Human Coagulation VIIa Market Drivers
13.3 Recombinant Human Coagulation VIIa Market Challenges
13.4 Recombinant Human Coagulation VIIa Market Restraints
14 Key Findings in The Global Recombinant Human Coagulation VIIa Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
Generium
List of Tables
    Table 1. Global Recombinant Human Coagulation VIIa Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Prefilled Syringe
    Table 3. Major Manufacturers of Vial
    Table 4. Global Recombinant Human Coagulation VIIa Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Recombinant Human Coagulation VIIa Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Recombinant Human Coagulation VIIa Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Recombinant Human Coagulation VIIa Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Recombinant Human Coagulation VIIa Revenue Market Share by Region (2019-2024)
    Table 9. Global Recombinant Human Coagulation VIIa Revenue Market Share by Region (2025-2030)
    Table 10. Global Recombinant Human Coagulation VIIa Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Recombinant Human Coagulation VIIa Sales by Region (2019-2024) & (K Units)
    Table 12. Global Recombinant Human Coagulation VIIa Sales by Region (2025-2030) & (K Units)
    Table 13. Global Recombinant Human Coagulation VIIa Sales Market Share by Region (2019-2024)
    Table 14. Global Recombinant Human Coagulation VIIa Sales Market Share by Region (2025-2030)
    Table 15. Global Recombinant Human Coagulation VIIa Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Recombinant Human Coagulation VIIa Sales Share by Manufacturers (2019-2024)
    Table 17. Global Recombinant Human Coagulation VIIa Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Recombinant Human Coagulation VIIa Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Recombinant Human Coagulation VIIa, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Recombinant Human Coagulation VIIa Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Recombinant Human Coagulation VIIa Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Recombinant Human Coagulation VIIa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Coagulation VIIa as of 2023)
    Table 23. Global Key Manufacturers of Recombinant Human Coagulation VIIa, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Recombinant Human Coagulation VIIa, Product Offered and Application
    Table 25. Global Key Manufacturers of Recombinant Human Coagulation VIIa, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Recombinant Human Coagulation VIIa Sales by Type (2019-2024) & (K Units)
    Table 28. Global Recombinant Human Coagulation VIIa Sales by Type (2025-2030) & (K Units)
    Table 29. Global Recombinant Human Coagulation VIIa Sales Share by Type (2019-2024)
    Table 30. Global Recombinant Human Coagulation VIIa Sales Share by Type (2025-2030)
    Table 31. Global Recombinant Human Coagulation VIIa Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Recombinant Human Coagulation VIIa Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Recombinant Human Coagulation VIIa Revenue Share by Type (2019-2024)
    Table 34. Global Recombinant Human Coagulation VIIa Revenue Share by Type (2025-2030)
    Table 35. Recombinant Human Coagulation VIIa Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Recombinant Human Coagulation VIIa Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Recombinant Human Coagulation VIIa Sales by Application (2019-2024) & (K Units)
    Table 38. Global Recombinant Human Coagulation VIIa Sales by Application (2025-2030) & (K Units)
    Table 39. Global Recombinant Human Coagulation VIIa Sales Share by Application (2019-2024)
    Table 40. Global Recombinant Human Coagulation VIIa Sales Share by Application (2025-2030)
    Table 41. Global Recombinant Human Coagulation VIIa Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Recombinant Human Coagulation VIIa Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Recombinant Human Coagulation VIIa Revenue Share by Application (2019-2024)
    Table 44. Global Recombinant Human Coagulation VIIa Revenue Share by Application (2025-2030)
    Table 45. Recombinant Human Coagulation VIIa Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Recombinant Human Coagulation VIIa Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Recombinant Human Coagulation VIIa Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Recombinant Human Coagulation VIIa Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Recombinant Human Coagulation VIIa Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Recombinant Human Coagulation VIIa Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Recombinant Human Coagulation VIIa Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Recombinant Human Coagulation VIIa Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Recombinant Human Coagulation VIIa Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Recombinant Human Coagulation VIIa Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Recombinant Human Coagulation VIIa Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Recombinant Human Coagulation VIIa Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Recombinant Human Coagulation VIIa Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Recombinant Human Coagulation VIIa Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Recombinant Human Coagulation VIIa Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Recombinant Human Coagulation VIIa Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Recombinant Human Coagulation VIIa Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Recombinant Human Coagulation VIIa Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Recombinant Human Coagulation VIIa Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Recombinant Human Coagulation VIIa Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Recombinant Human Coagulation VIIa Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Recombinant Human Coagulation VIIa Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Recombinant Human Coagulation VIIa Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Recombinant Human Coagulation VIIa Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Recombinant Human Coagulation VIIa Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Recombinant Human Coagulation VIIa Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Recombinant Human Coagulation VIIa Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Recombinant Human Coagulation VIIa Sales by Country (2025-2030) & (K Units)
    Table 73. China Recombinant Human Coagulation VIIa Sales by Type (2019-2024) & (K Units)
    Table 74. China Recombinant Human Coagulation VIIa Sales by Type (2025-2030) & (K Units)
    Table 75. China Recombinant Human Coagulation VIIa Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Recombinant Human Coagulation VIIa Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Recombinant Human Coagulation VIIa Sales by Application (2019-2024) & (K Units)
    Table 78. China Recombinant Human Coagulation VIIa Sales by Application (2025-2030) & (K Units)
    Table 79. China Recombinant Human Coagulation VIIa Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Recombinant Human Coagulation VIIa Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Recombinant Human Coagulation VIIa Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Recombinant Human Coagulation VIIa Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Recombinant Human Coagulation VIIa Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Recombinant Human Coagulation VIIa Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Recombinant Human Coagulation VIIa Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Recombinant Human Coagulation VIIa Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Recombinant Human Coagulation VIIa Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Recombinant Human Coagulation VIIa Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Recombinant Human Coagulation VIIa Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Recombinant Human Coagulation VIIa Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Recombinant Human Coagulation VIIa Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Recombinant Human Coagulation VIIa Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Recombinant Human Coagulation VIIa Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales by Country (2025-2030) & (K Units)
    Table 107. Novo Nordisk Company Information
    Table 108. Novo Nordisk Description and Major Businesses
    Table 109. Novo Nordisk Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Novo Nordisk Recombinant Human Coagulation VIIa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Novo Nordisk Recent Developments
    Table 112. LFB SA HEMA Biologics Company Information
    Table 113. LFB SA HEMA Biologics Description and Major Businesses
    Table 114. LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. LFB SA HEMA Biologics Recent Developments
    Table 117. AryoGen Pharmed Company Information
    Table 118. AryoGen Pharmed Description and Major Businesses
    Table 119. AryoGen Pharmed Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. AryoGen Pharmed Recombinant Human Coagulation VIIa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. AryoGen Pharmed Recent Developments
    Table 122. GENERIUM Company Information
    Table 123. GENERIUM Description and Major Businesses
    Table 124. GENERIUM Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. GENERIUM Recombinant Human Coagulation VIIa Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. GENERIUM Recent Developments
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Recombinant Human Coagulation VIIa Distributors List
    Table 130. Recombinant Human Coagulation VIIa Customers List
    Table 131. Recombinant Human Coagulation VIIa Market Trends
    Table 132. Recombinant Human Coagulation VIIa Market Drivers
    Table 133. Recombinant Human Coagulation VIIa Market Challenges
    Table 134. Recombinant Human Coagulation VIIa Market Restraints
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Human Coagulation VIIa Product Picture
    Figure 2. Global Recombinant Human Coagulation VIIa Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Recombinant Human Coagulation VIIa Market Share by Type in 2023 & 2030
    Figure 4. Prefilled Syringe Product Picture
    Figure 5. Vial Product Picture
    Figure 6. Global Recombinant Human Coagulation VIIa Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Recombinant Human Coagulation VIIa Market Share by Application in 2023 & 2030
    Figure 8. Congenital Hemophilia
    Figure 9. Acquired Hemophilia
    Figure 10. Others
    Figure 11. Recombinant Human Coagulation VIIa Report Years Considered
    Figure 12. Global Recombinant Human Coagulation VIIa Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Recombinant Human Coagulation VIIa Revenue 2019-2030 (US$ Million)
    Figure 14. Global Recombinant Human Coagulation VIIa Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Recombinant Human Coagulation VIIa Revenue Market Share by Region (2019-2030)
    Figure 16. Global Recombinant Human Coagulation VIIa Sales 2019-2030 ((K Units)
    Figure 17. Global Recombinant Human Coagulation VIIa Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Recombinant Human Coagulation VIIa Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Recombinant Human Coagulation VIIa Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Recombinant Human Coagulation VIIa Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Recombinant Human Coagulation VIIa Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Recombinant Human Coagulation VIIa Sales YoY (2019-2030) & (K Units)
    Figure 23. China Recombinant Human Coagulation VIIa Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Recombinant Human Coagulation VIIa Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Recombinant Human Coagulation VIIa Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Recombinant Human Coagulation VIIa Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Recombinant Human Coagulation VIIa in the World: Market Share by Recombinant Human Coagulation VIIa Revenue in 2023
    Figure 30. Global Recombinant Human Coagulation VIIa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Recombinant Human Coagulation VIIa Sales Market Share by Type (2019-2030)
    Figure 32. Global Recombinant Human Coagulation VIIa Revenue Market Share by Type (2019-2030)
    Figure 33. Global Recombinant Human Coagulation VIIa Sales Market Share by Application (2019-2030)
    Figure 34. Global Recombinant Human Coagulation VIIa Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Recombinant Human Coagulation VIIa Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Recombinant Human Coagulation VIIa Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Recombinant Human Coagulation VIIa Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Recombinant Human Coagulation VIIa Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Recombinant Human Coagulation VIIa Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Recombinant Human Coagulation VIIa Sales Share by Country (2019-2030)
    Figure 41. U.S. Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Recombinant Human Coagulation VIIa Sales Market Share by Type (2019-2030)
    Figure 44. Europe Recombinant Human Coagulation VIIa Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Recombinant Human Coagulation VIIa Sales Market Share by Application (2019-2030)
    Figure 46. Europe Recombinant Human Coagulation VIIa Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Recombinant Human Coagulation VIIa Revenue Share by Country (2019-2030)
    Figure 48. Europe Recombinant Human Coagulation VIIa Sales Share by Country (2019-2030)
    Figure 49. Germany Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 50. France Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 54. China Recombinant Human Coagulation VIIa Sales Market Share by Type (2019-2030)
    Figure 55. China Recombinant Human Coagulation VIIa Revenue Market Share by Type (2019-2030)
    Figure 56. China Recombinant Human Coagulation VIIa Sales Market Share by Application (2019-2030)
    Figure 57. China Recombinant Human Coagulation VIIa Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Recombinant Human Coagulation VIIa Sales Market Share by Type (2019-2030)
    Figure 59. Asia Recombinant Human Coagulation VIIa Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Recombinant Human Coagulation VIIa Sales Market Share by Application (2019-2030)
    Figure 61. Asia Recombinant Human Coagulation VIIa Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Recombinant Human Coagulation VIIa Revenue Share by Region (2019-2030)
    Figure 63. Asia Recombinant Human Coagulation VIIa Sales Share by Region (2019-2030)
    Figure 64. Japan Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 68. India Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Recombinant Human Coagulation VIIa Sales Share by Country (2019-2030)
    Figure 75. Brazil Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Recombinant Human Coagulation VIIa Revenue (2019-2030) & (US$ Million)
    Figure 80. Recombinant Human Coagulation VIIa Value Chain
    Figure 81. Recombinant Human Coagulation VIIa Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions